dr reddy's glp-1 drugs portfolio 2025 With the launch of our oral semaglutide biosimilar, Obeda® tablets, we are broadening our GLP‑1 to offer more choice and flexibility for patients. Oral semaglutide, as a convenient and flexible option Dr Reddy’s Steps Up Biosimilars

This approach differs from both traditional immunosuppression and even newer biologics

Monjaro (tirzepatide) activates both GIP and GLP-1 receptors

CJC-1295 with DAC laboratory research

Maintenance and prevention protocol Lower-dose combination approaches support ongoing tissue health and injury prevention in active individuals with chronic tissue demands

The best choice depends on your specific condition and goals

Follow @vasukifitness for more supplement truth bombs #Glutathione #MasterAntioxidant #SkinGlow DetoxSupport HealthInnov8 SupplementReview BeautyFromWithin NutritionWithGauri VasukiFitness HealthReels GlowUpNaturally Antioxidants SkincareFromInside ImmunityBoost | Vasuki Fitness